Vauth Roland, Löschmann Christoph, Rüsch Nicolas, Corrigan Patrick W
Department of Psychiatric Outpatient Treatment (Psychiatrische Universitätspoliklinik), University Hospital of Basel, Claragraben 95, CH-4005 Basel, Switzerland.
Psychiatry Res. 2004 Apr 15;126(1):43-9. doi: 10.1016/j.psychres.2003.07.004.
Understanding the factors that impede and promote adherence by people with schizophrenia to neuroleptic medication is important for treatment planning and relapse prevention. A total of 184 DSM-IV schizophrenia inpatients were examined with the Rating of Medication Influences (ROMI) scale within a context of inpatient vocational rehabilitation. Confirmatory factor analysis was used to evaluate the underlying dimensions of compliance behavior. The three-dimensional model of Weiden and his associates was confirmed by this study; specific factors included influence of others, medication affinity, and prevention. Additional analyses examined cognitive variables, symptoms, and course variables as predictors of individual factors. Verbal memory and cognitive flexibility were found to be associated with influence of others. Possible consequences for designing compliance enhancing therapeutic interventions are discussed.
了解阻碍和促进精神分裂症患者坚持使用抗精神病药物治疗的因素,对于治疗规划和预防复发至关重要。在住院职业康复的背景下,使用药物影响评定量表(ROMI)对184名符合《精神疾病诊断与统计手册》第四版(DSM-IV)标准的精神分裂症住院患者进行了检查。采用验证性因素分析来评估依从行为的潜在维度。本研究证实了魏登及其同事提出的三维模型;具体因素包括他人影响、药物亲和力和预防。进一步的分析将认知变量、症状和病程变量作为个体因素的预测指标进行了检验。研究发现言语记忆和认知灵活性与他人影响有关。文中还讨论了设计增强依从性治疗干预措施可能产生的后果。